Imax price target raised to $42 from $40 at Roth Capital

Core Viewpoint - Roth Capital analyst Eric Handler raised the price target on Imax (IMAX) to $42 from $40 while maintaining a Buy rating following the investor day, indicating confidence in the company's growth potential [1] Group 1: Analyst Insights - The company announced "bullish" near- and long-term targets that exceeded consensus estimates, suggesting strong future performance [1] - The firm believes Imax is well positioned for a "strong, multi-year growth cycle" due to its expanding box office market share [1]